Skip to main content
OpenTrials

Clinical trial condition

Narcolepsy Type 1

Explore clinical trials studying Narcolepsy Type 1. Study availability and eligibility vary by location and protocol.

30 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Narcolepsy Type 1 trial results

Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

NCT07598708

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +11 more
Locations
  • Miami, Florida Miami, Florida, United States
  • Miami Lakes, Florida Miami Lakes, Florida, United States
  • Denver, North Carolina Denver, North Carolina, United States
  • Huntersville, North Carolina Huntersville, North Carolina, United States
View all 15 locations
View Trial Details
Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

NCT06767683

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Idiopathic Hypersomnia, +10 more
Locations
  • Alkermes Investigator Site Phoenix, Arizona, United States
  • Alkermes Investigational Site Little Rock, Arkansas, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigator Site San Francisco, California, United States
View all 49 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

NCT07455383

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +10 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 29 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

NCT07540897

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +8 more
Locations
  • Alkermes Investigational Site Miami, Florida, United States
  • Alkermes Investigational Site Winter Park, Florida, United States
  • Alkermes Investigational Site Atlanta, Georgia, United States
  • Alkermes Investigational Site Macon, Georgia, United States
View all 14 locations
View Trial Details
Recruiting

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

NCT07633301

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +5 more
Locations
  • Takeda Site 12 Redwood City, California, United States
  • Takeda Site 14 Miami, Florida, United States
  • Takeda Site 13 Cincinnati, Ohio, United States
  • Takeda Site 2 Macquarie Park, New South Wales, Australia
View all 18 locations
View Trial Details
Recruiting

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

NCT07299097

Conditions
Narcolepsy Type 1, Narcolepsy Type 2
Locations
  • Hospital General de Castellón Castellon, Spain
  • Hospital de Navarra Pamplona, Navarre, Spain
  • Hospital de la Ribera Alzira, Valencia, Spain
  • Hospital Vall d'Hebrón Barcelona, Spain
View Trial Details

Related conditions